Overall Fundamental outlook

Business Operations:

Sector: Basic Materials
Industry: Specialty Chemicals

Clean Science and Technology Limited, research, develops, manufactures, and markets specialty chemicals in India and internationally. The company operates through Performance Chemicals, FMCG Chemicals, and Pharma & Agro Intermediates segments. It also offers FMCG Chemicals, including anisole, guaiacol, 4-methoxy acetophenone, butylated hydroxy anisole, veratrole, L-ascorbyl palmitate, tertiary butyl hydroquinone, ortho methoxy toluene, and para di-methoxy benzene (1,4-DMB). In addition, the company offers performance chemicals comprising clean light stab 770, 4-hydroxy tempo, mono methyl ether of hydroquinone, butylated hydroxy anisole, L-ascorbyl palmitate, 2,5-di-tertiary butyl hydroquinone, tertiary butyl hydroquinone, and dimethyl sebacate. Further, it provides pharma and agro intermediates, such as dicyclohexylcarbodimide, veratrole, para benzoquinone, and para di-methoxy benzene (1,4-DMB). Clean Science and Technology Limited serves food and infant food formulations, agricultural chemicals, polymers and monomers, perfumes, cosmetic, and other sectors. The company was incorporated in 2003 and is based in Pune, India.

Revenue projections:

Revenue projections for CLEAN
Revenue projections for CLEAN

Revenues for Clean Science and Technology Limited are forecasted to decline from last year's levels, prompting caution among investors. When revenues fall, it can have a significant negative impact on the company's bottom line, reducing profitability and making the stock less attractive to risk-averse investors.

Financial Ratios:

currentRatio 5.38000
forwardPE 26.35781
debtToEquity 0.14200
earningsGrowth -0.05800
revenueGrowth 0.02700
grossMargins 0.62582
operatingMargins 0.27907
trailingEps 24.95000
forwardEps 2970.79740

CLEAN's current ratio of 5.38, indicating that the company can meet its short-term debt obligations with ease. This high liquidity level is a positive sign, as CLEAN has enough cash and current assets to handle its immediate liabilities comfortably.
CLEAN's Forward PE being in a good range indicates the stock is priced well relative to its earnings. It is not overvalued, leaving space for future growth, making it an appealing option for investors interested in long-term value appreciation.
Clean Science and Technology Limited's low earnings and revenue growth suggest shrinking profits are likely. This could reflect broader financial struggles, signaling that the company might face difficulties in sustaining its profitability.
CLEAN's positive gross and operating margins indicate healthy profitability. These margins reflect the company's ability to generate income efficiently from its operations, signaling strong financial performance and effective cost management.
CLEAN's forward EPS exceeding its trailing EPS implies that the company is projected to be more profitable this year. This suggests an improvement in financial performance, with analysts expecting CLEAN to generate stronger earnings compared to the previous financial year.

Price projections:

Price projections for CLEAN
Price projections for CLEAN

CLEAN's current price concerning projections presents no discernible risks or opportunities. This balanced situation suggests a period of stability, where investors might consider holding their positions until more information becomes available.

Recommendation changes over time:

Recommendations trend for CLEAN
Recommendations trend for CLEAN


Analysts have maintained a buy bias for CLEAN, which could prompt investors to consider the stock as a viable investment. With this positive outlook, CLEAN is positioned as an attractive option for those looking to park their money in a stable and potentially lucrative company.